Time From Initial Community-Based Dementia Consultation to Confirmed Diagnosis: A Retrospective Analysis. [PDF]
Yamazaki A +3 more
europepmc +1 more source
Aquaporin‐4 in Narcolepsy Type 1: Investigation of Perivascular Fluid Movement in Sleep Disorders
ABSTRACT Narcolepsy type 1 (NT1) is caused by the loss of hypocretin‐1 leading to excessive daytime sleepiness and cataplexy. Additionally, disrupted nighttime sleep has become an increasingly recognized feature of NT1. As the glymphatic fluid movement has been linked to sleep architecture, we investigated cerebrospinal fluid (CSF) Aquaporin‐4 (AQP4 ...
Jonas Ranke +5 more
wiley +1 more source
Patients with chronic kidney disease stage 3b: do general practitioners and nephrologists follow KDIGO guidelines? [PDF]
Macedo JG +3 more
europepmc +1 more source
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto +12 more
wiley +1 more source
Effect of an in-consult patient decision aid on decisional quality and involvement for patients with severe hip or knee osteoarthritis: a multicenter, cluster randomized controlled trial. [PDF]
Pedersen TA +4 more
europepmc +1 more source
"Well advised" - Simulation of an ethical case consultation with students of evidence-based nursing, midwifery, and human medicine as part of an interprofessional education course. [PDF]
Vogel C +3 more
europepmc +1 more source
Individual Dietary Consultation Utilization and Patient-Reported Experiences Among People with Type 2 Diabetes in Israel: A Cross-Sectional Study. [PDF]
Kasher Meron M +10 more
europepmc +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source

